Taken together, our findings suggest that integrin α3β1 enhances breast cancer cell invasion through activation of an Akt signaling pathway and that this effect occurs partly through induction of Brn-2 (Figure 9A,B). The gene discussed is AKT1; the disease is breast carcinoma.